Oxofyline 200 mg (Tablet)
Unit Price: ৳ 6.00 (5 x 10: ৳ 300.00)
Strip Price: ৳ 60.00
Medicine Details
Category | Details |
---|---|
Generic | Doxophylline |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Indications
- Bronchial asthma
- Bronchospasm
- Chronic obstructive pulmonary disease (COPD)
- Pulmonary disease with spastic bronchial component
Pharmacology
Doxophylline is a novel bronchodilator. It selectively inhibits phosphodiesterase 4, relaxes bronchial smooth muscle, and has decreased affinities toward adenosine A1 and A2 receptors.
Dosage & Administration
- Elderly: 200 mg tablet two or three times daily
- Adults: 400 mg tablet two or three times daily
- Children:
- >12 years of age: 10 ml syrup or 200 mg tablet two or three times daily
- 6-12 years of age: 6-9 mg/kg body weight two times daily
- Special Dosage: If required daily dose of Doxophylline is 400 mg, Doxophylline SR tablet to be taken once daily or as prescribed by the physician
Interaction
- Not to be administered with other xanthine preparations
- Limit consumption of caffeine-containing beverages and food
- Caution with ephedrine or other sympathomimetic drugs
- Concurrent administration with erythromycin, TAO, lincomycin, clindamycin, allopurinol, cimetidine, influenza vaccine, propanolol, phenytoin, and other anticonvulsants may affect hepatic clearance
Contraindications
- Known hypersensitivity to the drug or other xanthine derivatives
- Acute myocardial infarction
- Hypotension
- Lactation
Side Effects
- Nausea
- Vomiting
- Epigastric pain
- Headache
- Irritability
- Insomnia
- Tachycardia
- Tachypnea
- Hyperglycemia (rare)
- Albuminuria (rare)
- Severe cardiac arrhythmias (in case of overdose)
- Tonic-clonic seizure (in case of overdose)
Pregnancy & Lactation
- Effects in Animals: No interference with pre and postnatal growth
- Clinical Use in Pregnancy: Should be evaluated carefully case by case based on risk-benefit ratio
- Lactation: Contraindicated
- Effects on ability to drive and use machines: No interference
Precautions & Warnings
- Factors may reduce hepatic clearance of xanthine derivatives
- Caution in patients with cardiac disease, hypertension, elderly, severe hypoxemia, hyperthyroidism, chronic corpulmonale, congestive heart failure, liver disease, peptic ulcer, renal impairment
- Monitoring of blood levels recommended in cases of factors influencing drug clearance
- Caution in patients with congestive heart failure due to slow drug clearance
Overdose Effects
Severe cardiac arrhythmias and tonic-clonic seizure may occur
Therapeutic Class
Bronchodilator, Methyl xanthine derivatives
Storage Conditions
Keep in a dry place away from light and heat. Keep out of the reach of children.